Related Experiment Video
Updated: May 12, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Properly diagnosing pulmonary arterial hypertension
1Pulmonary and Critical Care Division, New England Medical Center, Tufts University School of Medicine, 750 Washington Street, Boston, MA 02111, USA. ipreston@tuftsmedicalcenter.org
Diagnosing pulmonary hypertension (PH) requires careful evaluation to distinguish between different types, including pulmonary arterial hypertension (PAH). An algorithmic approach aids physicians in accurate classification and risk assessment for improved patient outcomes.
Area of Science:
- Cardiology
- Pulmonology
- Internal Medicine
Background:
- Pulmonary hypertension (PH) significantly increases morbidity and mortality.
- Pulmonary arterial hypertension (PAH) is a specific type of precapillary PH.
- Accurate diagnosis and classification of PH are crucial for patient management.
Purpose of the Study:
- To present a diagnostic algorithm for evaluating patients with suspected PH.
- To differentiate between various clinical PH groups, particularly PAH Group 1.
- To guide clinicians in identifying risk factors and specific etiologies of PH.
Main Methods:
- Systematic review of diagnostic investigations for PH.
- Development of a detailed clinical algorithm for PH categorization.
- Inclusion of case studies for differential diagnosis and management strategies.
Main Results:
- The algorithm facilitates the confirmation of PH diagnosis and determination of its clinical group.
- It aids in identifying etiologies associated with PAH Group 1 versus other PH groups.
- The approach helps in assessing functional and hemodynamic impairment and risk stratification.
Conclusions:
- A structured algorithmic approach is essential for accurate PH diagnosis and classification.
- Differentiating PAH Group 1 from other PH groups is critical for targeted therapy.
- Comprehensive evaluation, including risk factor identification, is necessary for optimal PH management.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Cardiac Catheterization II: Right Heart Catheterization
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

